-
2
-
-
0036240113
-
Behavioral and neurochemical effects of dopaminergic drugs in models of brain injury
-
Medico M, D'Vivo S, Tomasello C, et al. Behavioral and neurochemical effects of dopaminergic drugs in models of brain injury. Eur Neuropsychopharmacol 2000;12:187-94
-
(2000)
Eur Neuropsychopharmacol
, vol.12
, pp. 187-194
-
-
Medico, M.1
D'Vivo, S.2
Tomasello, C.3
-
3
-
-
0032588333
-
Free radicals scavengers: Chemical concept and clinical relevance
-
Gassen M, Youdim MB. Free radicals scavengers: chemical concept and clinical relevance. J Neural Transm 1999;56: 193-210
-
(1999)
J Neural Transm
, vol.56
, pp. 193-210
-
-
Gassen, M.1
Youdim, M.B.2
-
4
-
-
0030753786
-
In vitro identification of the P450 enzymes responsible for metabolism of ropinirole
-
Bloomer JC, Clarke SE, Chenery RJ. In vitro identification of the P450 enzymes responsible for metabolism of ropinirole. Drug Metab Dispos 1997;25:840-4
-
(1997)
Drug Metab Dispos
, vol.25
, pp. 840-844
-
-
Bloomer, J.C.1
Clarke, S.E.2
Chenery, R.J.3
-
5
-
-
0036865884
-
Innovations in design and delivery of chemotherapy for brain tumors
-
Gururangan S, Friedman HS. Innovations in design and delivery of chemotherapy for brain tumors. Neuroimaging Clin N Am 2009;12(4):583-97
-
(2009)
Neuroimaging Clin N Am
, vol.12
, Issue.4
, pp. 583-597
-
-
Gururangan, S.1
Friedman, H.S.2
-
6
-
-
84878760086
-
The mastermind approach to central nervous system drug therapy: Translational prediction of human brain distribution target site kinetics and therapeutic effects
-
de Lange EC. The mastermind approach to central nervous system drug therapy: translational prediction of human brain distribution, target site kinetics, and therapeutic effects. Fluids Barriers CNS 2013;10(1):12
-
(2013)
Fluids Barriers CNS
, vol.10
, Issue.1
, pp. 12
-
-
De Lange, E.C.1
-
7
-
-
0033300109
-
Development of a freeze dried formulation of insulin-loaded chitosan nanoparticles intended for nasal administration
-
Fernandez-Urrusuno R, Romani D, Calvo D. Development of a freeze dried formulation of insulin-loaded chitosan nanoparticles intended for nasal administration. STP Pharm Sci 1999;9: 429-36
-
(1999)
STP Pharm Sci
, vol.9
, pp. 429-436
-
-
Fernandez-Urrusuno, R.1
Romani, D.2
Calvo, D.3
-
8
-
-
0344185347
-
In-situ blood-brain barrier transport of nanoparticles
-
Koziara J, Lockman PR, Allen DD, Mumper RJ. In-situ blood-brain barrier transport of nanoparticles. Pharm Res 2003; 20(11):1772-8
-
(2003)
Pharm Res
, vol.20
, Issue.11
, pp. 1772-1778
-
-
Koziara, J.1
Lockman, P.R.2
Allen, D.D.3
Mumper, R.J.4
-
9
-
-
0242500461
-
In-vivo and in-vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles
-
Lockman PR, Koziara J, Roder KE, et al. In-vivo and in-vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles. Pharm Res 2003;20(5):705-13
-
(2003)
Pharm Res
, vol.20
, Issue.5
, pp. 705-713
-
-
Lockman, P.R.1
Koziara, J.2
Roder, K.E.3
-
10
-
-
0036205158
-
Nanoparticle technology for drug delivery across the blood-brain barrier
-
Lockman PR, Mumper RJ, Khan MA, Allen DD. Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Dev Ind Pharm 2002;28(1): 1-12
-
(2002)
Drug Dev Ind Pharm
, vol.28
, Issue.1
, pp. 1-12
-
-
Lockman, P.R.1
Mumper, R.J.2
Khan, M.A.3
Allen, D.D.4
-
11
-
-
0001437513
-
Using nanoparticles to target drugs to the central nervous system
-
Begley DJ Bradbury MW Kreuter J Editors Marcel Dekker; New York:
-
Kreuter J, Alyautdin RN. Using nanoparticles to target drugs to the central nervous system. In: Begley DJ, Bradbury MW, Kreuter J, Editors The Blood-Brain Barrier and Drug Delivery to the CNS. Marcel Dekker; New York: 2000. pp 205-23
-
(2000)
The Blood-Brain Barrier and Drug Delivery to the CNS
, pp. 205-223
-
-
Kreuter, J.1
Alyautdin, R.N.2
-
12
-
-
0037107001
-
Permeability issues in nasal drug delivery
-
Arora P, Sharma S, Garg S. Permeability issues in nasal drug delivery. Drug Discov Today 2002;7:967-75
-
(2002)
Drug Discov Today
, vol.7
, pp. 967-975
-
-
Arora, P.1
Sharma, S.2
Garg, S.3
-
13
-
-
3542998669
-
Nasal route and drug delivery systems
-
Turker S, Onur E, Ozer Y. Nasal route and drug delivery systems. Pharm World Sci 2002;26:137-42
-
(2002)
Pharm World Sci
, vol.26
, pp. 137-142
-
-
Turker, S.1
Onur, E.2
Ozer, Y.3
-
14
-
-
0034095651
-
Transport of drugs from the nasal cavity to the central nervous system
-
Illum L. Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci 2000;11:1-18
-
(2000)
Eur J Pharm Sci
, vol.11
, pp. 1-18
-
-
Illum, L.1
-
15
-
-
0031740593
-
Nasal route for direct delivery of solutes to the central nervous system: Fact or fiction
-
Mathison S, Nagilla R, Kompella UB. Nasal route for direct delivery of solutes to the central nervous system: fact or fiction. J Drug Target 1998;5:415-41
-
(1998)
J Drug Target
, vol.5
, pp. 415-441
-
-
Mathison, S.1
Nagilla, R.2
Kompella, U.B.3
-
16
-
-
28244473037
-
Study on brain targeting of raltitrexed following intranasal administration in rats
-
Dongxing W, Yongliang G, Liuhong Y. Study on brain targeting of raltitrexed following intranasal administration in rats. Cancer Chemother Pharmacol 2006;57: 97-104
-
(2006)
Cancer Chemother Pharmacol
, vol.57
, pp. 97-104
-
-
Dongxing, W.1
Yongliang, G.2
Liuhong, Y.3
-
17
-
-
0028131270
-
Nasal absorption of desmopressin in rats and sheep, effect of a bioadhesive microsphere delivery system
-
Critchley H, Davis SS, Farraj NF, Illum L. Nasal absorption of desmopressin in rats and sheep, effect of a bioadhesive microsphere delivery system. J Pharm Pharmacol 1994;46:651-6
-
(1994)
J Pharm Pharmacol
, vol.46
, pp. 651-656
-
-
Critchley, H.1
Davis, S.S.2
Farraj, N.F.3
Illum, L.4
-
18
-
-
0029881341
-
Bioadhesive and formulation parameters affecting nasal absorption
-
Dondeti P, Zia H, Needham TE. Bioadhesive and formulation parameters affecting nasal absorption. Int J Pharm 1996;127:115-33
-
(1996)
Int J Pharm
, vol.127
, pp. 115-133
-
-
Dondeti, P.1
Zia, H.2
Needham, T.E.3
-
19
-
-
0033389130
-
Transnasal delivery of 5-fluorouracil to the brain in the rat
-
Sakane T, Yamashita S, Yata N, et al. Transnasal delivery of 5-fluorouracil to the brain in the rat. J Drug Target 1999;7: 233-40
-
(1999)
J Drug Target
, vol.7
, pp. 233-240
-
-
Sakane, T.1
Yamashita, S.2
Yata, N.3
-
20
-
-
0042383364
-
Profiles of methotrexate in blood and CSF following intranasal and intravenous administration to rats
-
Wang F, Jiang X, Lu W. Profiles of methotrexate in blood and CSF following intranasal and intravenous administration to rats. Int J Pharm 2003;263:1-7
-
(2003)
Int J Pharm
, vol.263
, pp. 1-7
-
-
Wang, F.1
Jiang, X.2
Lu, W.3
-
22
-
-
0032961328
-
In vitro evaluation of micro particles and polymer gels for use as nasal plateform for protein delivery
-
Witschi C, Mrsny R. In vitro evaluation of micro particles and polymer gels for use as nasal plateform for protein delivery. Pharm Res 1999;16:382-90
-
(1999)
Pharm Res
, vol.16
, pp. 382-390
-
-
Witschi, C.1
Mrsny, R.2
-
23
-
-
0026800237
-
In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers
-
Lehr CM, Boustra JA, Schacht EH, Junginger HE. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int J Pharm 1992;78:43-58
-
(1992)
Int J Pharm
, vol.78
, pp. 43-58
-
-
Lehr, C.M.1
Boustra, J.A.2
Schacht, E.H.3
Junginger, H.E.4
-
24
-
-
0023277969
-
Nasal absorption of nifedipine from gel preparation in rats
-
Morimoto K, Tabata H, Morisaka K. Nasal absorption of nifedipine from gel preparation in rats. Chem Pharm Bull 1987;35:3141-4
-
(1987)
Chem Pharm Bull
, vol.35
, pp. 3141-3144
-
-
Morimoto, K.1
Tabata, H.2
Morisaka, K.3
-
25
-
-
0021984240
-
Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel
-
Morimoto K, Morisaka K, Kamada A. Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel. J Pharm Pharmacol 1985;37:134-6
-
(1985)
J Pharm Pharmacol
, vol.37
, pp. 134-136
-
-
Morimoto, K.1
Morisaka, K.2
Kamada, A.3
-
26
-
-
84861683682
-
Formulation development of chitosan coated intra nasal ropinirole nanoemulsion for better management option of Parkinson: An in vitro ex vivo evaluation
-
Mustafa G, Baboota S, Ahuja A, Ali J. Formulation Development of Chitosan Coated Intra Nasal Ropinirole Nanoemulsion for Better Management Option of Parkinson: An In Vitro Ex Vivo Evaluation. Current Nanosci 2012;8(3): 348-60
-
(2012)
Current Nanosci
, vol.8
, Issue.3
, pp. 348-360
-
-
Mustafa, G.1
Baboota, S.2
Ahuja, A.3
Ali, J.4
-
27
-
-
84866792172
-
Effect of homogenization on the fate of true nanoemulsion in brain translocation: A gamma scintigraphic evaluation
-
Mustafa G, Kumar N, Singh T, et al. Effect of homogenization on the fate of true nanoemulsion in brain translocation: A gamma scintigraphic evaluation. Sci Ad Material 2012c;4(7):739-48
-
(2012)
Sci Ad Material
, vol.4
, Issue.7
, pp. 739-748
-
-
Mustafa, G.1
Kumar, N.2
Singh, T.3
-
28
-
-
84882243842
-
C/ESI-Q-TOF-MS method for the measurement of dopamine in rodent striatal tissue: A comparative effects of intranasal administration of ropinirole solution over nanoemulsion
-
Mustafa G, Ahmad N, Baboota S, et al. C/ESI-Q-TOF-MS method for the measurement of dopamine in rodent striatal tissue: A comparative effects of intranasal administration of ropinirole solution over nanoemulsion. Drug Test Anal 2013;5(8): 702-9
-
(2013)
Drug Test Anal
, vol.5
, Issue.8
, pp. 702-709
-
-
Mustafa, G.1
Ahmad, N.2
Baboota, S.3
-
29
-
-
84870208203
-
A new method for radiolabeling of human immunoglobulin-G and its biological evaluation
-
Singh T, Kumar N, Soni S, et al. A new method for radiolabeling of human immunoglobulin-G and its biological evaluation. J Pharm Bioallied Sci 2012;4(4): 286-90
-
(2012)
J Pharm Bioallied Sci
, vol.4
, Issue.4
, pp. 286-290
-
-
Singh, T.1
Kumar, N.2
Soni, S.3
-
30
-
-
33645345962
-
Intranasal mucoad-hesive microemulsions of clonazepam: Preliminary studies on brain targeting
-
Tushar K, Vyas AK, Babbar RK, et al. Intranasal mucoad-hesive Microemulsions of Clonazepam: Preliminary Studies on Brain Targeting. J Pharm Sci 2006;3:570-80
-
(2006)
J Pharm Sci
, vol.3
, pp. 570-580
-
-
Tushar, K.1
Vyas, A.K.2
Babbar, R.K.3
-
31
-
-
84901288353
-
Optimised nanoformulation of bromocriptine for direct nose-to-brain delivery: Biodistribution, pharmacokinetic and dopamine estimation by ultra-HPLC/mass spectrometry method
-
[Epub ahead of print]
-
Md S, Haque S, Fazil M, et al. Optimised nanoformulation of bromocriptine for direct nose-to-brain delivery: biodistribution, pharmacokinetic and dopamine estimation by ultra-HPLC/mass spectrometry method. Expert Opin Drug Deliv 2014. [Epub ahead of print]
-
(2014)
Expert Opin Drug Deliv
-
-
Md, S.1
Haque, S.2
Fazil, M.3
-
32
-
-
84870367030
-
Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: A pharmacoscintigraphic study
-
Alam S, Khan ZI, Mustafa G, et al. Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study. Int J Nanomedicine 2012;7:5705-18
-
(2012)
Int J Nanomedicine
, vol.7
, pp. 5705-5718
-
-
Alam, S.1
Khan, Z.I.2
Mustafa, G.3
-
33
-
-
34548041658
-
Targeting the central nervous system: In vivo experiments with peptide-derivatized NPs loaded with loperamide and rhodamine-123
-
Tosi G, Costantino L, Rivasi F, et al. Targeting the central nervous system: In vivo experiments with peptide-derivatized NPs loaded with loperamide and rhodamine-123. J Control Release 2007;122:1-9
-
(2007)
J Control Release
, vol.122
, pp. 1-9
-
-
Tosi, G.1
Costantino, L.2
Rivasi, F.3
-
34
-
-
0031757312
-
BBB transport using MDR 1A and wild-type mice Total brain versus microdialysis concentration profiles of Rhodamine-123
-
Lange EC, Bock GD, Shinkel AH, et al. BBB transport using MDR 1A and wild-type mice. Total brain versus microdialysis concentration profiles of Rhodamine-123. Pharm Res 1998;15: 1657-65
-
(1998)
Pharm Res
, vol.15
, pp. 1657-1665
-
-
Lange, E.C.1
Bock, G.D.2
Shinkel, A.H.3
-
35
-
-
84860214736
-
Venlafaxine loaded chitosan NPs for brain targeting: Pharmacokinetic and pharmacodynamic evaluation
-
Haque S, Md S, Fazil M, et al. Venlafaxine loaded chitosan NPs for brain targeting: Pharmacokinetic and pharmacodynamic evaluation. Carbohydr Polym 2012;89(1): 72-9
-
(2012)
Carbohydr Polym
, vol.89
, Issue.1
, pp. 72-79
-
-
Haque, S.1
Md, S.2
Fazil, M.3
-
37
-
-
23944510393
-
Neuroprotection by crocetin in a hemi-parkinsonian rat model
-
Ahmad AS, Ansari MA, Ahmad M, et al. Neuroprotection by crocetin in a hemi-parkinsonian rat model. Pharmacol Biochem Behav 2005;81(4):805-13
-
(2005)
Pharmacol Biochem Behav
, vol.81
, Issue.4
, pp. 805-813
-
-
Ahmad, A.S.1
Ansari, M.A.2
Ahmad, M.3
-
38
-
-
0036421309
-
Involvement of intrinsic cholinergic and GABAergic innervation in the effect of NMDA on striatal dopamine efflux and metabolism as assessed by microdialysis studies in freely moving rats
-
Whitehead J, Rose S, Jenner P. Involvement of intrinsic cholinergic and GABAergic innervation in the effect of NMDA on striatal dopamine efflux and metabolism as assessed by microdialysis studies in freely moving rats. Eur J Neurosci 2001;14: 851-60
-
(2001)
Eur J Neurosci
, vol.14
, pp. 851-860
-
-
Whitehead, J.1
Rose, S.2
Jenner, P.3
-
39
-
-
61349098481
-
Antagonism of haloperidol-induced swim impairment in l-dopa and caffeine treated mice: A pre-clinical model to study Parkinson's disease
-
Luthra PM, Barodia SK, Raghubir R. Antagonism of haloperidol-induced swim impairment in l-dopa and caffeine treated mice: A pre-clinical model to study Parkinson's disease. J Neurosci Methods 2009;178(2):284-90
-
(2009)
J Neurosci Methods
, vol.178
, Issue.2
, pp. 284-290
-
-
Luthra, P.M.1
Barodia, S.K.2
Raghubir, R.3
-
40
-
-
84865107235
-
Stressed kinetics of nanoemulsion formulation encapsulated ropinirole with a validated ultra high performance liquid chromatography-synapt mass spectrometry (UPLC-MS/MS ESI-Q-TOF)
-
Mustafa G, Ahmad N, Baboota S, et al. Stressed kinetics of nanoemulsion formulation encapsulated ropinirole with a validated ultra high performance liquid chromatography-synapt mass spectrometry (UPLC-MS/MS ESI-Q-TOF). J Chin Chem Soc 2012a;59:8-1021-30
-
(2012)
J Chin Chem Soc
, vol.59
, Issue.8
, pp. 1021-1030
-
-
Mustafa, G.1
Ahmad, N.2
Baboota, S.3
-
41
-
-
24644465494
-
Intranasal mucoadhesive microemulsions of zolmitriptan: Preliminary studies on brain-targeting
-
Vyas TK, Babbar AK, Sharma RK, Misra A. Intranasal mucoadhesive microemulsions of zolmitriptan: preliminary studies on brain-targeting. J Drug Target 2005;13(5): 317-24
-
(2005)
J Drug Target
, vol.13
, Issue.5
, pp. 317-324
-
-
Vyas, T.K.1
Babbar, A.K.2
Sharma, R.K.3
Misra, A.4
-
42
-
-
0016151122
-
Bromobenzeneinduced liver necrosis Protective role of glutathione and evidence for 3, 4-bromobenzene oxide as the hepatotoxic metabolite
-
Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR. Bromobenzeneinduced liver necrosis Protective role of glutathione and evidence for 3, 4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 1974;11:151-69
-
(1974)
Pharmacology
, vol.11
, pp. 151-169
-
-
Jollow, D.J.1
Mitchell, J.R.2
Zampaglione, N.3
Gillette, J.R.4
-
43
-
-
84868239948
-
Design, synthesis and evaluation of N-(substituted benzothiazol-2-yl) amides as anticonvulsant and neuroprotectiveq
-
Hassan MZ, Khan SA, Amir M. Design, synthesis and evaluation of N-(substituted benzothiazol-2-yl) amides as anticonvulsant and neuroprotectiveq. Eur J Med Chem 2012;58:206-13
-
(2012)
Eur J Med Chem
, vol.58
, pp. 206-213
-
-
Hassan, M.Z.1
Khan, S.A.2
Amir, M.3
-
44
-
-
0242384066
-
Protective effect of adenosine in rat model of Parkinson's disease: Neurobehavioral and neurochemical evidences
-
Zafar SK, Siddiqui A, Sayeed I, et al. Protective effect of adenosine in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences. J Chem Neuroanat 2003;26:143-51
-
(2003)
J Chem Neuroanat
, vol.26
, pp. 143-151
-
-
Zafar, S.K.1
Siddiqui, A.2
Sayeed, I.3
-
45
-
-
0031783879
-
Chitosan and its use as a pharmaceutical excipient
-
Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm Res 1998;15:1326-31
-
(1998)
Pharm Res
, vol.15
, pp. 1326-1331
-
-
Illum, L.1
-
46
-
-
7444268954
-
Recent advances on chitosan based micro-and nanoparticles in drug delivery
-
Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan based micro-and nanoparticles in drug delivery. J Control Rel 2004;100:5-28
-
(2004)
J Control Rel
, vol.100
, pp. 5-28
-
-
Agnihotri, S.A.1
Mallikarjuna, N.N.2
Aminabhavi, T.M.3
-
47
-
-
0030958672
-
Delivery of 125I-NGF to the brain via the olfactory route
-
Frey WH, Liu J, Chen X, et al. Delivery of 125I-NGF to the brain via the olfactory route. Drug Deliv 1997;4:87-92
-
(1997)
Drug Deliv
, vol.4
, pp. 87-92
-
-
Frey, W.H.1
Liu, J.2
Chen, X.3
-
48
-
-
77949388122
-
Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats
-
Khan S, Patil K, Bobade N, et al. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats. J Drug Target 2010;18(3): 223-34
-
(2010)
J Drug Target
, vol.18
, Issue.3
, pp. 223-234
-
-
Khan, S.1
Patil, K.2
Bobade, N.3
-
49
-
-
84880942253
-
Nose to Brain targeting potential of a chitosan coated nanoformulation: Pharmacodynamic and Pharmacoscintigraphic evaluation
-
Mustafa G, Baboota S, Ali J, et al. Nose to Brain targeting potential of a chitosan coated nanoformulation: Pharmacodynamic and Pharmacoscintigraphic evaluation. Sci Adv Mat 2013;5:9.1236-49
-
(2013)
Sci Adv Mat
, vol.5
, Issue.9
, pp. 1236-1249
-
-
Mustafa, G.1
Baboota, S.2
Ali, J.3
-
50
-
-
84872412539
-
Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: Pharmacodynamic, Pharmacokinetic and Scintigraphy study in mice model
-
Md S, Khan RA, Mustafa G, et al. Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: Pharmacodynamic, Pharmacokinetic and Scintigraphy study in mice model. Eur J Pharm Sci 2012;48(3):393-405
-
(2012)
Eur J Pharm Sci
, vol.48
, Issue.3
, pp. 393-405
-
-
Md, S.1
Khan, R.A.2
Mustafa, G.3
-
51
-
-
10644263255
-
Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption
-
Smith JM, Dornish M. Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption. Biomaterials 2005;26(16): 3269-76
-
(2005)
Biomaterials
, vol.26
, Issue.16
, pp. 3269-3276
-
-
Smith, J.M.1
Dornish, M.2
-
52
-
-
0028071051
-
Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2)
-
Artursson P, Lindmark T, Davis SS, Illum L. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm Res 1994;11:1358-61
-
(1994)
Pharm Res
, vol.11
, pp. 1358-1361
-
-
Artursson, P.1
Lindmark, T.2
Davis, S.S.3
Illum, L.4
-
53
-
-
0032971987
-
Evaluation of the clearance characteristics of bioadhesive systems in humans
-
Soane RJ, Frier M, Perkins AC, et al. Evaluation of the clearance characteristics of bioadhesive systems in humans. Int J Pharm 1999;178:55-65
-
(1999)
Int J Pharm
, vol.178
, pp. 55-65
-
-
Soane, R.J.1
Frier, M.2
Perkins, A.C.3
-
54
-
-
0037436997
-
Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats
-
Dufes C, Olivier JC, Gaillard F. Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats. Int J Pharm 2003;255:87-97
-
(2003)
Int J Pharm
, vol.255
, pp. 87-97
-
-
Dufes, C.1
Olivier, J.C.2
Gaillard, F.3
-
55
-
-
3242668754
-
Oxidative stress to dopaminergic neurons as models of Parkinson's disease
-
Gille G, Hung ST, Reichmann H, Rausch WD. Oxidative stress to dopaminergic neurons as models of Parkinson's disease. Ann NY Acad Sci 2004;1018:533-40
-
(2004)
Ann NY Acad Sci
, vol.1018
, pp. 533-540
-
-
Gille, G.1
Hung, S.T.2
Reichmann, H.3
Rausch, W.D.4
|